Patents by Inventor Venkata Garigapati

Venkata Garigapati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7964561
    Abstract: Liquid formulations of bone morphogenetic proteins are provided for prolonged use at elevated temperatures. More specifically, the invention relates to liquid formulations comprising rhGDF-5, trehalose, and one or more biocompatible excipients that provide stability to the protein for at least 30 days at temperatures up to body temperature.
    Type: Grant
    Filed: January 28, 2010
    Date of Patent: June 21, 2011
    Assignee: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: Venkata Garigapati, Dongling Su, Julius Lopez
  • Publication number: 20100130730
    Abstract: Liquid formulations of bone morphogenetic proteins are provided for prolonged use at elevated temperatures. More specifically, the invention relates to liquid formulations comprising rhGDF-5, trehalose, and one or more biocompatible excipients that provide stability to the protein for at least 30 days at temperatures up to body temperature.
    Type: Application
    Filed: January 28, 2010
    Publication date: May 27, 2010
    Applicant: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: Venkata Garigapati, Dongling Su, Julius Lopez
  • Patent number: 7678764
    Abstract: Liquid formulations of bone morphogenetic proteins are provided for prolonged use at elevated temperatures. More specifically, the invention relates to liquid formulations comprising rhGDF-5, trehalose, and one or more biocompatible excipients that provide stability to the protein for at least 30 days at temperatures up to body temperature.
    Type: Grant
    Filed: June 24, 2008
    Date of Patent: March 16, 2010
    Assignee: Johnson & Johnson Regenerative Therapeutics, LLC
    Inventors: Venkata Garigapati, Dongling Su, Julius Lopez
  • Publication number: 20090318343
    Abstract: Liquid formulations of bone morphogenetic proteins are provided for prolonged use at elevated temperatures. More specifically, the invention relates to liquid formulations comprising rhGDF-5, trehalose, and one or more biocompatible excipients that provide stability to the protein for at least 30 days at temperatures up to body temperature.
    Type: Application
    Filed: June 24, 2008
    Publication date: December 24, 2009
    Inventors: Venkata Garigapati, Dongling Su, Julius Lopez
  • Publication number: 20050085535
    Abstract: The invention features a method for treating obesity in a patient by administering to the patient a polymer that has been substituted with one or more groups that inhibit lipases, which are enzymes responsible for the hydrolysis of fat. The invention further relates to the polymers employed in the methods described herein as well as novel intermediates and methods for preparing the polymers.
    Type: Application
    Filed: October 7, 2004
    Publication date: April 21, 2005
    Applicant: Genzyme Corporation
    Inventors: W. Mandeville, Molly Boie, Venkata Garigapati